Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VENETOCLAX vs VFEND: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VENETOCLAX vs VFEND: Safety Overview

Metric VENETOCLAX VFEND
Total FAERS Reports 53,724 182
Deaths Reported 15,763 49
Death Rate 29.3% 26.9%
Hospitalizations 20,812 61
Average Patient Age 67.9 yrs 60.2 yrs
% Female Patients 37.6% N/A
FDA Approval Date Apr 11, 2016 N/A
Manufacturer AbbVie Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A